PEBL, a component-based Chinese medicine, reduces virus-induced acute lung injury by targeting FXR to decrease ACE2 levels. - Yang, Liling; Zhou, Xiangjun; Liu, Junshan; Yang, Guangli; Tan, Weifu; Ding, Hongyan; Fang, Xiaochuan; Yu, Jingtao; Li, Wei; He, Jiayang; Cao, Huihui; Ma, Qinhai; et al. (Journal of Advanced Research, 2026)